The latest closing stock price for Orgenesis as of December 27, 2024 is 2.84.
An investor who bought $1,000 worth of Orgenesis stock at the IPO in 2018 would have $-979 today, roughly -1 times their original investment - a -42.61% compound annual growth rate over 7 years.
The all-time high Orgenesis stock closing price was 146.80 on March 15, 2018.
The Orgenesis 52-week high stock price is 10.80, which is 280.3% above the current share price.
The Orgenesis 52-week low stock price is 1.25, which is 56% below the current share price.
The average Orgenesis stock price for the last 52 weeks is 5.69.
An investor who bought $1,000 worth of Orgenesis stock at the IPO in 2018 would have $-979 today, roughly -1 times their original investment - a -42.61% compound annual growth rate over 7 years.
The all-time high Orgenesis stock closing price was 146.80 on March 15, 2018.
The Orgenesis 52-week high stock price is 10.80, which is 280.3% above the current share price.
The Orgenesis 52-week low stock price is 1.25, which is 56% below the current share price.
The average Orgenesis stock price for the last 52 weeks is 5.69.